Dept. of Oncology and Molecular Medicine
Fabrizio Mattei has not added Biography.
If you are Fabrizio Mattei and would like to personalize this page please email our Author Liaison for assistance.
ICSBP is essential for the development of mouse type I interferon-producing cells and for the generation and activation of CD8alpha(+) dendritic cells.
The Journal of experimental medicine Dec, 2002 | Pubmed ID: 12461077
ICSBP is critically involved in the normal development and trafficking of Langerhans cells and dermal dendritic cells.
Blood Mar, 2004 | Pubmed ID: 14615368
ICSBP/IRF-8 differentially regulates antigen uptake during dendritic-cell development and affects antigen presentation to CD4+ T cells.
Blood Jul, 2006 | Pubmed ID: 16569763
Type I IFN regulate DC turnover in vivo.
European journal of immunology Jul, 2009 | Pubmed ID: 19544312
Regulation of immune cell homeostasis by type I interferons.
Cytokine & growth factor reviews Aug, 2010 | Pubmed ID: 20627800
Cyclophosphamide synergizes with type I interferons through systemic dendritic cell reactivation and induction of immunogenic tumor apoptosis.
Cancer research Feb, 2011 | Pubmed ID: 21156650
Type I IFNs control antigen retention and survival of CD8α(+) dendritic cells after uptake of tumor apoptotic cells leading to cross-priming.
Journal of immunology (Baltimore, Md. : 1950) May, 2011 | Pubmed ID: 21441457
IRF-8 controls melanoma progression by regulating the cross talk between cancer and immune cells within the tumor microenvironment.
Neoplasia (New York, N.Y.) Dec, 2012 | Pubmed ID: 23308054
TIM-3 as a molecular switch for tumor escape from innate immunity.
Frontiers in immunology , 2012 | Pubmed ID: 23316202
Novel allergic asthma model demonstrates ST2-dependent dendritic cell targeting by cypress pollen.
The Journal of allergy and clinical immunology Sep, 2013 | Pubmed ID: 23608732
The tumor microenvironment: a pitch for multiple players.
Frontiers in oncology , 2013 | Pubmed ID: 23616948
Interferon regulatory factor 8-deficiency determines massive neutrophil recruitment but T cell defect in fast growing granulomas during tuberculosis.
PloS one , 2013 | Pubmed ID: 23717393
Mycobacterium tuberculosis PstS1 amplifies IFN-γ and induces IL-17/IL-22 responses by unrelated memory CD4+ T cells via dendritic cell activation.
European journal of immunology Sep, 2013 | Pubmed ID: 23719937
The dual role of IRF8 in cancer immunosurveillance.
Oncoimmunology Aug, 2013 | Pubmed ID: 24175153
Type I Interferons as Stimulators of DC-Mediated Cross-Priming: Impact on Anti-Tumor Response.
Frontiers in immunology Dec, 2013 | Pubmed ID: 24400008
Cancer-driven dynamics of immune cells in a microfluidic environment.
Scientific reports Oct, 2014 | Pubmed ID: 25322144
Classification of current anticancer immunotherapies.
Oncotarget Dec, 2014 | Pubmed ID: 25537519
Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1.
Science (New York, N.Y.) Nov, 2015 | Pubmed ID: 26516201
Combining Type I Interferons and 5-Aza-2'-Deoxycitidine to improve anti-tumor response against melanoma.
The Journal of investigative dermatology Sep, 2016 | Pubmed ID: 27623509
IL-33 restricts tumor growth and inhibits pulmonary metastasis in melanoma-bearing mice through eosinophils.
Oncoimmunology , 2017 | Pubmed ID: 28680750
Organs on chip approach: a tool to evaluate cancer -immune cells interactions.
Scientific reports 10, 2017 | Pubmed ID: 28986543
Eosinophils: The unsung heroes in cancer?
Oncoimmunology , 2018 | Pubmed ID: 29308325
Acidic microenvironment plays a key role in human melanoma progression through a sustained exosome mediated transfer of clinically relevant metastatic molecules.
Journal of experimental & clinical cancer research : CR Oct, 2018 | Pubmed ID: 30290833
The Pleiotropic Immunomodulatory Functions of IL-33 and Its Implications in Tumor Immunity.
Frontiers in immunology , 2018 | Pubmed ID: 30483263
From Petri Dishes to Organ on Chip Platform: The Increasing Importance of Machine Learning and Image Analysis.
Frontiers in pharmacology , 2019 | Pubmed ID: 30863306
IL-33 Promotes CD11b/CD18-Mediated Adhesion of Eosinophils to Cancer Cells and Synapse-Polarized Degranulation Leading to Tumor Cell Killing.
Cancers Oct, 2019 | Pubmed ID: 31717819
High-throughput analysis of cell-cell crosstalk in ad hoc designed microfluidic chips for oncoimmunology applications.
Methods in enzymology , 2020 | Pubmed ID: 32000911
Basophils in Tumor Microenvironment and Surroundings.
Advances in experimental medicine and biology , 2020 | Pubmed ID: 32036602
Tumor-Intrinsic or Drug-Induced Immunogenicity Dictates the Therapeutic Success of the PD1/PDL Axis Blockade.
Cells 04, 2020 | Pubmed ID: 32290265
Is There a Role for Basophils in Cancer?
Frontiers in immunology , 2020 | Pubmed ID: 33013885
Eosinophils in the Tumor Microenvironment.
Advances in experimental medicine and biology , 2020 | Pubmed ID: 33119873
Anti-Tumorigenic Activities of IL-33: A Mechanistic Insight.
Frontiers in immunology , 2020 | Pubmed ID: 33329534
A Clonogenic Assay to Quantify Melanoma Micrometastases in Pulmonary Tissue.
Methods in molecular biology (Clifton, N.J.) , 2021 | Pubmed ID: 33704729
Oncoimmunology Meets Organs-on-Chip.
Frontiers in molecular biosciences , 2021 | Pubmed ID: 33842539
Copyright © 2024 MyJoVE Corporation. Alle Rechte vorbehalten